Biowatch

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market

The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly expanding into the realm of oral...
Deceptive Symptoms in Diagnostic Gaps: 88% of Pediatric Pneumonia Cases Coincide with Viruses

Deceptive Symptoms in Diagnostic Gaps: 88% of Pediatric Pneumonia Cases Coincide with Viruses

Diagnosing respiratory infections in infants and toddlers using virus-only testing can leave dangerous diagnostic gaps, frequently missing...
31 Bottles Per Person: Kwangdong Corn Silk Tea Marks 20th Anniversary With 1.6 Billion Bottles Sold

31 Bottles Per Person: Kwangdong Corn Silk Tea Marks 20th Anniversary With 1.6 Billion Bottles Sold

For South Koreans looking for a refreshing, caffeine-free beverage, it is a staple that almost everyone has tried at...
Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo,...
Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion Secures South Korean Phase 1 Approval for Tremfya Biosimilar CT-P68

Celltrion announced on July 15 that it has received approval from South Korea’s Ministry of Food and Drug Safety for an...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines

Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines

South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully...
Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion...
Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients

Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient:...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...